13 years 🥳 of Publication, 100k+ Stories, 30+ Countries
Search
Latham & Watkins Advises Ascendis Pharma A/S in Its Royalty Funding Agreement With Royalty Pharma
Ascendis Pharma A/S (Nasdaq: ASND) and Royalty Pharma plc (Nasdaq: RPRX) announced that Ascendis has entered into a US$150 million…
Latham & Watkins Advises NextGen Healthcare in Acquisition by Thoma Bravo
NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, announced that it has entered into…
Latham & Watkins Advises on Permian Resources’ US$500 Million Private Placement of Senior Notes
Permian Resources Corporation (NYSE: PR) announced that its subsidiary, Permian Resources Operating, LLC (the Issuer), has priced US$500 million in…
Latham & Watkins Advises on Andretti Acquisition Corp.’s Business Combination With Zapata AI
Zapata Computing, Inc. (Zapata AI), the Industrial Generative AI software company developing solutions and applications to solve enterprises’ hardest problems,…
Latham & Watkins Advises LeanIX Investors on Sale to SAP
Latham & Watkins LLP has advised the investors of LeanIX, a leading company in the field of Enterprise Architecture Management…
Hogan Lovells welcomes Dentons duo into Infrastructure and Energy M&A practice in Berlin
Global law firm Hogan Lovells is pleased to announce that Dr Thomas Dörmer and Dr Tim Heitling are joining the…
